| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/07/2008 | CN100386072C Nanometer dragon's blood capsule and its preparation method |
| 05/06/2008 | US7368578 superior in an adipose tissue weight decreasing action and a retinoid-related receptor function regulating action; to treat obesity, diabetes mellitus, hyperlipidemia, impaired glucose tolerance, hypertension; fewer side effects; 4-{[2-(2-furyl)-1,3-oxazol-4-yl]methoxy}-3-methoxybenzaldehyde |
| 05/06/2008 | US7368563 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, alzheimer's, demyelination and lowering plasma levels of sterols |
| 05/06/2008 | US7368562 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, demyelination and lowering plasma levels of sterols |
| 05/06/2008 | US7368553 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy |
| 05/06/2008 | US7368469 Prophylaxis of stroke, cardiovascular death or myocardial infarction by administering an angiotenzin converting enzyme inhibitor: ramipril, ramiprilat or their salts, optionally together with another antihypertensive, a cholesterol lowering agent, a diuretic or aspirin |
| 05/06/2008 | US7368465 Metalloproteinase inhibitors |
| 05/06/2008 | US7368459 Heterocyclic compounds |
| 05/06/2008 | US7368450 Sodium channel blockers |
| 05/06/2008 | US7368448 2-(arylalkoxy)-1-phenylethylamine derivatives as NK1 antagonist and serotonin reuptake inhibitors |
| 05/06/2008 | US7368427 GLP-1 analogues |
| 05/06/2008 | US7368295 Nanoparticles comprising biologically active TNF which is immobilized on the same |
| 05/06/2008 | US7368270 Polynucleotide encoding polypeptide having phosphatidylserine-specific activity; lipid metabolism enzymes used in diagnosis, treatment, and prevention of cancer, neurological, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 05/06/2008 | US7368144 Removal of shell, pulp; grinding in presence of solvent; macerating, extraction. filtration |
| 05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2376780C Intraocular tension lowering compositions for topical administration |
| 05/06/2008 | CA2322229C Compositions comprising heparin and soluble tnf receptors for inhibition of tnf activity |
| 05/06/2008 | CA2280727C Bicyclic amino acids |
| 05/06/2008 | CA2239694C Indane dimer compounds and their pharmaceutical use |
| 05/02/2008 | WO2008052044A2 Use of derivatives of propofol for treating diseases associated with oxidative stress |
| 05/02/2008 | WO2008051875A2 Adamantylurea compounds as soluble epoxide hydrolase inhibitors |
| 05/02/2008 | WO2008051873A2 Phenylurea compounds as soluble epoxide hydrolase inhibitors |
| 05/02/2008 | WO2008051047A1 Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same |
| 05/02/2008 | WO2008050848A1 Adhesive preparation |
| 05/02/2008 | WO2008050808A1 2-aminoquinazoline derivative |
| 05/02/2008 | WO2008050789A1 Use of interleukin-11 as therapeutic agent for heart disease |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008050600A1 Therapeutic or preventive agent for intractable disease based on oxidative stress-mediated cell death as molecular background |
| 05/02/2008 | WO2008050483A1 Cardiovascular preparation |
| 05/02/2008 | WO2008050200A1 Oxadiazole compounds as calcium channel antagonists |
| 05/02/2008 | WO2008049855A2 7-azaindole derivatives as c-met kinase inhibitors |
| 05/02/2008 | WO2008049227A1 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 05/02/2008 | WO2008010225A3 Enhancement of regulatory t cells' activity using statins |
| 05/02/2008 | WO2007147899B1 Dha esters and use thereof in treatment and prevention of cardiovascular disease |
| 05/02/2008 | CA2693383A1 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 05/02/2008 | CA2667231A1 Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients |
| 05/02/2008 | CA2666606A1 Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 05/02/2008 | CA2666497A1 Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 05/02/2008 | CA2666482A1 Soluble epoxide hydrolase inhibitors |
| 05/02/2008 | CA2648243A1 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 05/01/2008 | US20080103457 Method and System for Treating Heart Failure |
| 05/01/2008 | US20080103208 Poly(ADP-ribose) polymerase inhibitor is preferably 3-nitro-4-iodobenzamide; administered orally, topically, parenerally, transdermally, or rectally; anticarcinogenic and antidiabetic agents; obesity, cardiovascular disease |
| 05/01/2008 | US20080103200 Levodopa prodrugs, and compositions and uses thereof |
| 05/01/2008 | US20080103185 Chloroacylation of 4-[(2,4-dioxothiazolidin-5-yl)methyl]phenoxyacetic acid; amidation of tert-butyl N-(2-amino-5-methoxyphenyl)-N-methylcarbamate; cyclizing to 5-{4-[(6-methoxy-1-methyl-1H-benzimidazol-2-yl)methoxy]benzyl}thiazolidine-2,4-dione; reflux purification; highly stable antidiabetic agents |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103179 For treating diabetes, hypertension, migraine, epilepsy, sleep apnea, depression, impulse control disorders or alcohol addiction; coadministering a sympathomimetic agent such as phentermine and an anticonvulsant sulfamate or sulfonylurea, preferably topiramate or zonisamide; side effect reduction |
| 05/01/2008 | US20080103156 Bicyclic Heteroaromatic Compounds |
| 05/01/2008 | US20080103137 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 05/01/2008 | US20080103118 Composition for improving blood cholesterol levels |
| 05/01/2008 | US20080103115 Phosphonate compounds |
| 05/01/2008 | US20080102144 Fat beta-oxidation enhancing and carbohydrate absorption inhibition supplement |
| 05/01/2008 | US20080102034 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102033 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102031 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction |
| 04/30/2008 | EP1916247A1 Activator of peroxisome proliferator activated receptor |
| 04/30/2008 | EP1916241A1 Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 04/30/2008 | EP1915993A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/30/2008 | EP1915391A1 Sra binding protein |
| 04/30/2008 | EP1915377A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors |
| 04/30/2008 | EP1915369A1 Novel substituted 1,2,3-t ii azolylmethyl-benzothiophene or -indole and their use as leukotiiene biosynthesis inhibitors |
| 04/30/2008 | EP1915152A2 Method for the protection against the risk of cardiac disorders comprising administration of tiotropium salts |
| 04/30/2008 | EP1915144A2 Method to reduce oxidative damage and improve mitochondrial efficiency |
| 04/30/2008 | EP1915141A1 Method of use of deacetylase inhibitors |
| 04/30/2008 | EP1716118B1 Tetrahydrobenzo[d]azepin-2- one derivatives and the use thereof for treating cardiovascular diseases |
| 04/30/2008 | EP1615936A4 Phosphates of secondary alcohols |
| 04/30/2008 | EP1531805B1 Composition devoid of ascorbic acid comprising a cholesterol absorption inhibitor, an hmg-coa reductase inhibitor and a stabilizing agent |
| 04/30/2008 | EP1307486B1 Somatostatin analogues |
| 04/30/2008 | EP1213297B1 Tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 04/30/2008 | EP1212417B1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 04/30/2008 | EP1165613B1 Melanocortin receptor ligands |
| 04/30/2008 | DE102006050516A1 New pyrazol-3-one compounds are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful e.g. to treat and/or prophylaxis heart-circulation diseases, heart failure, anemia, chronic kidney diseases and renal failure |
| 04/30/2008 | DE102006050515A1 New substituted dipyridiyl-dihydropyrazolone derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases, heart failure and anemia |
| 04/30/2008 | DE102006050513A1 New substituted dihydropyrazolone derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases, heart failure and anemia |
| 04/30/2008 | DE102006050512A1 New substituted dihydropyrazole- and dihydrotriazole derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases and anemia |
| 04/30/2008 | DE102006050511A1 New substituted dihydrotriazolone compounds are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat or prophylaxis e.g. heart insufficiency, anemia, chronic kidney diseases and renal failure |
| 04/30/2008 | DE102006050510A1 New substituted dihydropyrazolthione compounds are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat or prevent e.g. heart insufficiency, anemia, chronic kidney diseases and renal failure |
| 04/30/2008 | CN101171246A Stable micronized candesartan cilexetil and methods for preparing thereof |
| 04/30/2008 | CN101171025A Novel nutraceutical compositions |
| 04/30/2008 | CN101171024A Blood pressure lowering protein hydrolysates |
| 04/30/2008 | CN101171007A The use of rapamycin derivatives for the treatment and/or prevention of cardiovascular disorders |
| 04/30/2008 | CN101168762A Method for preparing antihypertensive peptide from hairtail backbone by fermentation method |
| 04/30/2008 | CN101168042A Traditional Chinese medicine preparation for curing cardiovascular and cerebrovascular diseases and preparing method |
| 04/30/2008 | CN101168021A Medicine for treating cardio-cerebral disease |
| 04/30/2008 | CN101167951A Traditional Chinese medicinal composition for treating diabetes and its preparation method |
| 04/30/2008 | CN101167943A Wine capable of prolonging life |
| 04/30/2008 | CN101167922A Traditional Chinese medicine preparation |
| 04/30/2008 | CN101167913A Pus-drawing out medicine powder for externally treating internal illness |
| 04/30/2008 | CN101167910A Oral liquid traditional Chinese medicine for treating cerebral thrombus sequelae |
| 04/30/2008 | CN101167889A Traditional Chinese medicine for treating syncope and rheumatoid arthritis |
| 04/30/2008 | CN101167888A Traditional Chinese medicine preparation for reducing blood pressure and regulating blood lipid |
| 04/30/2008 | CN101167885A Traditional Chinese medicine sticking block for treating hypertension |
| 04/30/2008 | CN101167877A Medicinal composition for treating high blood pressure and its complication and preparation method thereof |
| 04/30/2008 | CN101167876A Medicinal composition for treating high blood pressure and its complication and preparation method thereof |
| 04/30/2008 | CN101167873A Technology for processing honey-prepared glutinous rehmannia |
| 04/30/2008 | CN101167838A Traditional Chinese medicinal preparation for treating coronary heart disease and angina pectoris and its preparing process |
| 04/30/2008 | CN101167813A Medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 04/30/2008 | CN101167806A Medicinal composition for treating hypertension and preparation method |
| 04/30/2008 | CN101167801A Method for preparing scutellaria dispensing granule |
| 04/30/2008 | CN101167797A American ginseng and ligusticum wallichii refreshment compound preparation |